BioCentury
ARTICLE | Clinical News

Galaczym regulatory update

October 10, 2011 7:00 AM UTC

The European Commission granted Orphan Drug designation for Galaczym from Zymenex's Ace Biosciences A/S subsidiary to treat globoid cell leukodystrophy (Krabbe disease), a hereditary disease caused by...